Enlivex Therapeutics Ltd (ENLV) — Cash Flow Reinvestment Rate
Latest as of March 2020:
2.62x
Enlivex Therapeutics Ltd (ENLV) has a Cash Flow Reinvestment Rate of 2.62x as of March 2020, reinvesting ILA2.04 Million (capex ILA39.00K plus investments ILA-2.00 Million) from operating cash flow of ILA779.00K. Explore cash flow conversion of Enlivex Therapeutics Ltd to assess how effectively this company generates cash.
Reinvestment Rate
2.62x
(Capex + Investments) / Operating CF
Total Reinvested
ILA2.04 Million
Capex + Investments
Operating Cash Flow
ILA779.00K
ILA
Capital Expenditures
ILA39.00K
ILA
Annual Cash Flow Reinvestment Rate for Enlivex Therapeutics Ltd (None–None)
Year-by-year capital reinvestment analysis for Enlivex Therapeutics Ltd. For live market cap and broader valuation context, see ENLV stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow